CB Therapeutics and atai Life Sciences launch TryptageniX to sustainably supply and develop clinically relevant compounds to tackle the growing mental health crisis
TryptageniX will research and develop new sustainable methods of manufacturing therapeutic compounds commercially with increased…
BOMESI Foundation Opens Fifth Accelerator Cohort For Diverse-Owned Media Publishers And Creators
Ynvisible Advances Commercial Program with Sapphiros, Announces CFO Appointment and Adoption of Semi-Annual Financial Reporting
Airwheel SE3SX AI Wheel Luxury Suitcase Wins 2026 WGA for Smart Electric Riding Carry-On Hand Luggage
Syntheia Signs Definitive Agreement for Sale of Call Center Assets and Announces Shares for Debt Transaction